Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
1(6%)
Results Posted
43%(3 trials)
Terminated
2(12%)

Phase Distribution

Ph phase_1
2
12%
Ph phase_2
4
24%
Ph not_applicable
7
41%
Ph phase_3
2
12%
Ph phase_4
2
12%

Phase Distribution

2

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
2(11.8%)
Phase 2Efficacy & side effects
4(23.5%)
Phase 3Large-scale testing
2(11.8%)
Phase 4Post-market surveillance
2(11.8%)
N/ANon-phased studies
7(41.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

17

all time

Status Distribution
Active(4)
Completed(7)
Terminated(3)
Other(3)

Detailed Status

Completed7
Not yet recruiting3
Terminated2
unknown2
Recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
1
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (11.8%)
Phase 24 (23.5%)
Phase 32 (11.8%)
Phase 42 (11.8%)
N/A7 (41.2%)

Trials by Status

not_yet_recruiting318%
completed741%
terminated212%
recruiting16%
unknown212%
suspended16%
withdrawn16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07572890Phase 2

Adia Med of Winter Park LLC Chronic Kidney Disease Research Study

Not Yet Recruiting
NCT07400016Not Applicable

Efficacy of Superoxide Dismutase Spray in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .

Not Yet Recruiting
NCT07273799Phase 3

Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia

Not Yet Recruiting
NCT02991365Not Applicable

Effect of Weight Loss on Brain Insulin Sensitivity in Humans

Recruiting
NCT05383300Not Applicable

Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy

Completed
NCT04808531Phase 3

NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers

Unknown
NCT03929419Not Applicable

"Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"

Completed
NCT04793997Not Applicable

Microbiome Therapy in Covid-19 Primary Care Support

Suspended
NCT03443843Phase 4

A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure

Completed
NCT03484832Phase 4

Spray vs EMLA Cream on Pain During Intra-articular Injection

Unknown
NCT02409862Phase 2

Faces: Choices Study

Withdrawn
NCT01747850Phase 2

Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence

Completed
NCT01723397Not Applicable

Effect of Nasaleze on Nasal Challenge With Allergen

Terminated
NCT02457806Phase 1

Comparison of Anesthetic Efficacy of Bilateral and Unillateral Application of Kovacaine Mist in Healthy Volunteers

Completed
NCT01823146Not Applicable

Oxytocin's Effect on Socioemotional Aging

Completed
NCT01021176Phase 1

Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell

Terminated
NCT01361802Phase 2

Ambroxol Spray Sore Throat Study

Completed

All 17 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
17